Publication date: Jul 09, 2025
Background/Objectives: The COVID-19 pandemic has caused sickness and death among many health care workers. However, the apparent resistance of health care workers to SARS-CoV-2 infection despite their high-risk work environment remains unclear. To investigate if inflammation and circadian disruption contribute to resistance or diminished susceptibility to the SARS-CoV-2 virus, we retrospectively evaluated a cohort of volunteer hospital nurses (VHNs). Methods: A total of 246 apparently healthy VHNs (mean age 37. 4 +/- 5. 9 years) who had received the BNT162b2 mRNA vaccine were asked to report their sleep quality, according to the Pittsburgh Sleep Quality Index, and number of SARS-CoV-2 infections during the observational study period (from the end of December 2020 to April 2025). The expression of inflammation-associated mediators and circadian transcription factors in peripheral blood mononuclear cells, as well as sleep quality, were examined. Results: Our findings revealed no anthropometric, biochemical, or inflammation-associated parameters but demonstrated significantly greater levels of NFE2L2, also known as nuclear factor erythroid-derived 2-like 2 (NFR2), gene expression in peripheral blood mononuclear cells among VHNs who had never been infected with SARS-CoV-2 (n = 97) than in VHNs with only one (n = 119) or with two or more (n = 35) prior SARS-CoV-2 infections (p < 0. 01). This result was confirmed through one-to-one propensity score matching (p < 0. 01). Moreover, NRF2 gene expression was not associated with the number of COVID-19 vaccinations (p = 0. 598). Finally, NRF2 gene expression was higher among participants who reported better sleep quality (p < 0. 01). Conclusions: Our findings suggest possible interactions among NRF2 gene expression, protection against SARS-CoV-2 infection, and the modulation of COVID-19 vaccination efficacy.

Open Access PDF
| Concepts | Keywords |
|---|---|
| Basel | anti-S-RBD IgG antibody |
| Nurses | COVID-19 |
| Pandemic | healthcare workers |
| Sleep | SARS-CoV-2 |
| vaccine |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | SARS-CoV-2 Infection |
| pathway | REACTOME | SARS-CoV-2 Infection |
| disease | MESH | death |
| disease | MESH | inflammation |
| disease | IDO | susceptibility |
| disease | MESH | sleep quality |
| disease | IDO | blood |
| drug | DRUGBANK | Tropicamide |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | infections |
| disease | MESH | occupational disease |
| pathway | KEGG | Circadian rhythm |
| disease | IDO | production |
| disease | MESH | cytokine storm |
| disease | MESH | liver disease |
| disease | MESH | heart failure |
| disease | IDO | history |
| disease | MESH | cancer |
| disease | MESH | hepatitis |
| drug | DRUGBANK | Melatonin |
| disease | MESH | sleep latency |
| drug | DRUGBANK | Dextrose unspecified form |
| disease | IDO | infection |
| disease | MESH | recurrence |
| drug | DRUGBANK | Cholesterol |